Skip to Main Content

Paper Details

MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
Alzheimers Dement
42
2021
AD, Alzheimer's Disease, Alzheimer's Project, Alzheimer's disease, Cerebral small vessel diseases, Dementia, Neurologic Diseases, Participant, Stroke, UDS3, Uniform, VCID, advanced small vessel disease, arteriolosclerosis, biomarker, brain injuries, cardioembolism, cardiovascular disease, cerebral amyloid angiopathy, cerebral small vessel disease, cerebral small vessel diseases, cerebrovascular processes, cholesterol, cognitive impairment, creatinine, dementia, diseases of the small cerebral vessels, embolic infarcts, ethylenediaminetetraacetic acid, frontotemporal and Lewy body dementia, hemoglobin A1c, human, neurodegenerative pathologies, overt strokes, packed cells, participant, participants, patient, platelet-poor plasma, polystyrene, risk, small vessel disease, small vessel pathologies, stroke, triglycerides, vascular and mixed dementia
Author NameAffiliation
Gregory A JichaUniversity of Kentucky College of Medicine
Marilyn AlbertJohns Hopkins University School of Medicine
Myriam FornageMcGovern Medical School and Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston, Brown Foundation Institute of Molecular Medicine
Joel H KramerDavid Geffen School of Medicine, University of California Los Angeles
Melissa LamarRush University
Melissa LamarRush University
Russell P TracyUniversity of Vermont Larner College of Medicine
Karl G HelmerMassachusetts General Hospital
Karl G HelmerMassachusetts General Hospital
Steven M GreenbergMassachusetts General Hospital
  • 1 - 10

Datasets